Literature DB >> 9061323

Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.

M W Tomlinson1, M C Treadwell, G Deppe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9061323

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN： 0392-2936            Impact factor:   0.196


× No keyword cloud information.
  4 in total

1.  Fertility-sparing management and obstetric outcomes in a 20-year-old patient with a Sertoli-Leydig cell tumor of the ovary: A case report and review of the literature.

Authors:  Thomas Stavrakis; Ioannis Kalogiannidis; Stamatios Petousis; Chrisoula Tsompanidou; Dimitris Delkos; Nikolaos Prapas; David Rousso
Journal:  Oncol Lett       Date:  2016-06-09       Impact factor: 2.967

2.  A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution.

Authors:  Seon Mi Nam; Jee Whan Kim; Kyung Jin Eoh; Hye Min Kim; Jung Yun Lee; Eun Ji Nam; Sunghoon Kim; Sang Wun Kim; Young Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

Review 3.  A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Authors:  Stergios Boussios; Michele Moschetta; Konstantina Tatsi; Alexandros K Tsiouris; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2018-03-06       Impact factor: 10.479

4.  Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.

Authors:  Kyung Jin Eoh; Junsik Park; Hye Min Kim; Maria Lee; Young Tae Kim
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 2.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.